Ex-Generic Drug Maker Files Chapter 11 Plan

Able Laboratories Inc., the former pharmaceutical developer that sold off its assets to India's Sun Pharmaceutical Industries Ltd. last year, is pursuing a Chapter 11 plan designed to pay back unsecured...

Already a subscriber? Click here to view full article